GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 85 filers reported holding GALENA BIOPHARMA INC in Q4 2014. The put-call ratio across all filers is 1.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $99,000 | -24.4% | 281,597 | 0.0% | 0.00% | – |
Q2 2016 | $131,000 | -62.9% | 281,597 | +8.5% | 0.00% | -100.0% |
Q1 2016 | $353,000 | -7.3% | 259,427 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $381,000 | -7.1% | 259,427 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $410,000 | -1.2% | 259,427 | +6.3% | 0.00% | 0.0% |
Q2 2015 | $415,000 | +71.5% | 244,089 | +40.4% | 0.00% | – |
Q1 2015 | $242,000 | -2.8% | 173,839 | +5.3% | 0.00% | – |
Q4 2014 | $249,000 | -26.8% | 165,118 | 0.0% | 0.00% | -100.0% |
Q3 2014 | $340,000 | -32.7% | 165,118 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $505,000 | +5.9% | 165,118 | -13.4% | 0.00% | 0.0% |
Q1 2014 | $477,000 | -33.9% | 190,604 | +31.0% | 0.00% | -50.0% |
Q4 2013 | $722,000 | +106.3% | 145,554 | -5.6% | 0.00% | +100.0% |
Q3 2013 | $350,000 | +47.1% | 154,241 | +44.1% | 0.00% | 0.0% |
Q2 2013 | $238,000 | – | 107,006 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Spark Investment Management LLC | 308,500 | $462,000 | 0.08% |
Perceptive Advisors | 200,000 | $302,000 | 0.02% |
DUMONT & BLAKE INVESTMENT ADVISORS LLC | 29,675 | $45,000 | 0.02% |
EXANE DERIVATIVES | 100,000 | $150,995,000 | 0.02% |
PIPER SANDLER & CO. | 20,000 | $30,000 | 0.02% |
Alyeska Investment Group, L.P. | 530,000 | $801,000 | 0.01% |
COMPTON CAPITAL MANAGEMENT INC /RI | 15,000 | $23,000 | 0.01% |
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 13,350 | $20,000 | 0.01% |
GROUP ONE TRADING, L.P. | 458,952 | $693,000 | 0.01% |
WOLVERINE ASSET MANAGEMENT LLC | 1,605 | $388,000 | 0.01% |